Prestige Consumer Healthcare (PBH) Change in Cash (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Change in Cash of -$56.7 million in Q4 2025, down 178.16% quarter-over-quarter from -$20.4 million in Q3 2025, and down 8418.47% on a YoY basis from $682012.6 in Q4 2024.
Prestige Consumer Healthcare (PBH) Change in Cash (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Cash history runs 16 years deep, the most recent figure standing at -$56.7 million for Q4 2025.
- In Q4 2025, Change in Cash fell 8418.47% year-over-year to -$56.7 million; the TTM figure through Dec 2025 stood at $11.5 million (up 190.25% YoY), while the FY2025 annual figure was $51.4 million, up 527.75% from the prior year.
- Change in Cash was -$56.7 million for Q4 2025 at Prestige Consumer Healthcare, down from -$20.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $131.3 million in Q2 2021 to a low of -$120.8 million in Q3 2021.
- Historically, Change in Cash has averaged $13500.0 across 5 years, with a median of $1.4 million in 2023.
- The sharpest annual moves came in 2021 and 2025: Change in Cash jumped 456.67% in 2021, then sank 8418.47% in 2025.
- A 5-year view of Change in Cash shows it stood at -$21.8 million in 2021, then soared by 301.45% to $43.9 million in 2022, then plunged by 91.92% to $3.5 million in 2023, then tumbled by 118.77% to -$666000.0 in 2024, then tumbled by 8418.47% to -$56.7 million in 2025.
- The last three Change in Cash figures came in at -$56.7 million (Q4 2025), -$20.4 million (Q3 2025), and $41.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 185.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -509.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -117.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.23 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -6.35 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.47 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | -56.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -56.73 Mn |
| Sep 30, 2025 | -20.40 Mn |
| Jun 30, 2025 | 41.62 Mn |
| Mar 31, 2025 | 47.01 Mn |
| Dec 31, 2024 | -666,000.00 |
| Sep 30, 2024 | 17.28 Mn |
| Jun 30, 2024 | -12.21 Mn |
| Mar 31, 2024 | -17.15 Mn |
| Dec 31, 2023 | 3.55 Mn |
| Sep 30, 2023 | 5.49 Mn |
| Jun 30, 2023 | -3.91 Mn |
| Mar 31, 2023 | -27.87 Mn |
| Dec 31, 2022 | 43.92 Mn |
| Sep 30, 2022 | 6.57 Mn |
| Jun 30, 2022 | 8.68 Mn |
| Mar 31, 2022 | 6.17 Mn |
| Dec 31, 2021 | -21.80 Mn |
| Sep 30, 2021 | -120.81 Mn |
| Jun 30, 2021 | 131.32 Mn |
| Mar 31, 2021 | -29.80 Mn |